This inventor holds 1 USPTO granted patent. Top assignee: Myelos Corporation. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Michael T White: Innovator in Neurotrophic Peptides
Introduction
Michael T White is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of neurotrophic and analgesic peptides. His work focuses on developing innovative solutions for treating central and peripheral nervous system disorders.
Latest Patents
Michael T White holds a patent for "Retro-inverso neurotrophic and analgesic peptides." This patent involves retro-inverso peptide analogs derived from the active neurotrophic region of saposin C. The saposin C-derived peptides, known as prosaptides, induce neurite outgrowth in vitro, prevent programmed cell death, induce myelination, and have an analgesic effect. These peptides are particularly useful in pain management and the treatment of various nervous system disorders. Notably, the retro-inverso peptides are significantly more resistant to metabolic degradation than their non-inverted counterparts. He has 1 patent to his name.
Career Highlights
Michael T White is associated with Myelos Corporation, where he continues to advance his research and development efforts. His work has the potential to impact the medical field significantly, particularly in the areas of neurology and pain management.
Collaborations
Some of his notable coworkers include John S O'Brien and David Erick Wright. Their collaboration enhances the innovative environment at Myelos Corporation, fostering advancements in peptide research.
Conclusion
Michael T White is a key figure in the development of neurotrophic peptides, with a focus on improving treatments for nervous system disorders. His innovative work at Myelos Corporation continues to pave the way for future advancements in this critical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
